Teveten
Company: SmithKline Beecham
Approval Status: Approved December 1997
Treatment for: hypertension
Areas: Cardiology/Vascular Diseases; Endocrinology
Possible similar drugs: Teveten HCT
| General Information | Mechanism of Action |
General Information
Other Useful Resources
Teveten was approved for the treatment of hypertension, as either a monotherapy or for use in combination with other antihypertensives.
Mechanism of Action
Teveten is an angiotensin II antagonist.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
